Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| WESTELL TECH | WSTL | 6.67% |
| STEIN MART I | SMRT | 5.38% |
| ALLIANCE FIB | AFOP | 5.21% |
| DAWSON GEOPH | DWSN | 4.33% |
| MARRIOTT VAC | VAC | 3.27% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
As a part of its annual review, the rating agency A.M.Best, yesterday disclosed its findings on UnitedHealth Group Inc. ( UNH - Analyst Report ) and its subsidiaries. Details of the findings are as follows :
The rating agency acknowledges UnitedHealth’s significant market niche and diversified business operations with no more than 37% coming from any one segment. The largest exposure is commercial risk at 37% followed by Medicare Advantage at 27% and the remaining segments are under 10%. A.M.Best also finds the company’s size (it is largest publicly traded health insurer based on revenue) favorable.
However, A.M.Best is concerned with high debt leverage, which stood at 30.1% at the end of third quarter 2010. Also, a large amount of goodwill in the company’s balance sheet due to several acquisitions is a cause for worry.
Another offsetting factor is the earnings improvement seen at the company in fiscal 2010 compared with the prior year due to lower medical ratios. However, with the mandatory compliance of minimum medical ratios, the company will have to give rebates to members or increase the medical ratios to the required level, which may result in an earnings decline.
UnitedHealth, along with other players in the health insurance sector -- CIGNA Corp. ( CI - Analyst Report ) , Humana Inc. ( HUM - Analyst Report ) and Welllpoint Inc. (WLP), is exposed to the uncertainties that surfaced due to the recently enacted health care reform.
The anticipated headwinds include: a continued weak employment outlook; continued state and municipal budget deficits; the phase-down of enhanced Federal Medical Assistance Percentage (FMAP) in mid 2011; higher costs related to the implementation of health care reform; challenging Medicare Advantage rates for the second consecutive year; a continued low interest rate environment pressuring investment income, and higher expenses to prepare for compliance with the federally mandated ICD-10 coding and HIPAA 5010 standards.
Read the full Analyst Report on HUM
Read the full Analyst Report on CI
Read the full Analyst Report on UNH